PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 7, 2026Nature Communications0 citationsOpen Access

NH600001, an etomidate analogue, provides gastrointestinal endoscopy sedation/anesthesia and reduces adrenocortical depression: two randomized controlled trials

View Full Paper
YZYingyong ZhouKDKaiming DuanSLShichao Luo

Key Points

  • The aim is to evaluate the sedative effects of NH600001 compared to etomidate and its impact on adrenocortical function.
  • Conducted two randomized controlled trials to compare NH600001 with etomidate in gastrointestinal endoscopy sedation.
  • Performed in Changsha, China, with clinical trial identifiers ChiCTR2300069841 and ChiCTR2400084095.
  • NH600001 provided significantly higher sedation levels compared to etomidate (P < 0.001).
  • NH600001 demonstrated a comparable safety profile and resulted in fewer myoclonus adverse events than etomidate.

Abstract

in the NH600001 group, versus the etomidate group, were significantly higher (P < 0.001). Furthermore, NH600001 had a safety profile comparable to etomidate and elicited fewer myoclonus adverse events. In Conclusions, NH600001 has a sedative/anesthetic effect comparable to etomidate while reducing the risk of adrenocortical depression with a favorable safety profile. Chictr.org.cn identifier: ChiCTR2300069841, ChiCTR2400084095. Clinical Trial Number and Registry URL: NH60001-21, Identifier, ChiCTR2300069841 (Changsha, China;, principal investigator: Wen Ouyang, first registration date: March 28, 2023), https://www.chictr.org.cn; NH60001-31, Identifier, ChiCTR2400084095 (Changsha, China, principal investigator: Wen Ouyang, first registration date: May 10, 2024), https://www.chictr.org.cn.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhou et al. (2026) studied this question.

synapsesocial.com/papers/69fc2ba98b49bacb8b34795ehttps://doi.org/10.1038/s41467-026-72614-2
Ask AI
Helpful
Bookmark
Share
View Full Paper